Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of afamelanotide in patients with Variegate Porphyria has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Variegate Porphyria

Drugs mentioned

• SCENESSE (afamelanotide)

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Variegate Porphyria | Phase 2 | Status: COMPLETED | Results posted: 2025-04-27